Clinical Trial Update: Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of RGH-896 in patients with diabetic peripheral neuropathic pain; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain

Drugs mentioned

• RGH-896

Snippet

Sponsor: Forest Laboratories | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: COMPLETED